05:06 PM EST, 01/21/2025 (MT Newswires) -- Masimo ( MASI ) late Tuesday said Katie Szyman has been selected as the new chief executive officer at the medical device company, succeeding interim CEO Michelle Brennan, who was appointed to be the new chair of Masimo's ( MASI ) board of directors.

Both moves take effect on Feb. 12, the company said.

Szyman currently is the worldwide president for advanced patient monitoring at Becton, Dickinson (BD) and previously led the critical care product group at Edwards Lifesciences before its acquisition by BD in September 2024.

Brennan temporarily became CEO at Masimo ( MASI ) on Sept. 25 after Joe Kiani disclosed plans to step down from the company. The former Johnson & Johnson senior executive was elected to the Masimo ( MASI ) board in 2023.